Mountain is losing ground
CriticalMountain averages -7.1% QoQ across 1 investigators ($234K 12-month revenue).
Commission a regional performance review for Mountain this quarter.
Portfolio signals derived from live PI, contract, study and operations data.
What changed this period
CNS leads growth at +13.2%, 3 investigators posted negative QoQ revenue, and 5 contracts are inside a 10-day SLA window.
4 insights
Mountain is losing ground
CriticalMountain averages -7.1% QoQ across 1 investigators ($234K 12-month revenue).
Commission a regional performance review for Mountain this quarter.
3 investigators with declining revenue
CriticalDr. Amanda Foster (-7.1%), Dr. Emily Rodriguez (-4.8%), Dr. Kevin Brown (-2.4%) posted negative quarter-over-quarter revenue.
Flag these investigators for a joint finance and operations review.
Contract bottleneck risk
Critical5 contracts (C-1002, C-1004, C-1005, C-1008, C-1009) are within 5–10 days of their review SLA, the earliest expiring in 18 days.
Escalate these to legal and counterparty reviewers for same-week turnaround.
Compliance and documentation risk
Critical2 critical operational alerts are open and 3 investigators sit below 85% compliance (Kevin Brown, Emily Rodriguez, Amanda Foster).
Run a documentation remediation sprint at the affected sites before month end.
3 insights
Therapeutic area spread
WatchCNS is growing +13.2% on $701K, while Infectious Diseases has stalled at +1.0% on $510K.
Rebalance business development effort toward Infectious Diseases or reduce its allocated capacity.
Enrollment coverage
Watch4 of 6 tracked studies are under 85% of enrollment target (NEURO-2024-007 76%, IMMUNO-2024-003 81%, ONCO-2024-008 84%, NEURO-2024-015 68%).
Reallocate screening resources to the lagging studies for the next two cycles.
Network footprint concentration
InfoSouth holds 75 PIs (36% of the network), the largest single-region concentration.
Plan continuity cover for South to reduce single-region dependency.
2 insights
Midwest is the strongest region
PositiveMidwest averages +9.4% QoQ revenue growth on $412K of 12-month revenue — the best trajectory in the portfolio.
Route incoming sponsor studies toward Midwest while capacity holds.
Contract execution steady
Positive3 of 10 contracts are fully executed, with an average of 18 days from draft to current stage.
Keep the current review cadence; publish turnaround times to sponsors.